Gagnon Securities LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 107.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 23,239 shares of the medical equipment provider’s stock after buying an additional 12,055 shares during the period. Intuitive Surgical accounts for approximately 3.1% of Gagnon Securities LLC’s holdings, making the stock its 10th largest position. Gagnon Securities LLC’s holdings in Intuitive Surgical were worth $13,339,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the stock. CENTRAL TRUST Co raised its position in Intuitive Surgical by 26.4% in the 3rd quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock valued at $264,000 after purchasing an additional 96 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in Intuitive Surgical by 25.7% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 14,564 shares of the medical equipment provider’s stock valued at $8,360,000 after purchasing an additional 2,977 shares during the last quarter. Carillon Tower Advisers Inc. raised its position in Intuitive Surgical by 3.7% in the 3rd quarter. Carillon Tower Advisers Inc. now owns 77,953 shares of the medical equipment provider’s stock valued at $44,745,000 after purchasing an additional 2,754 shares during the last quarter. Signition LP bought a new position in Intuitive Surgical in the 2nd quarter valued at $240,000. Finally, United Capital Management of KS Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $205,000. 84.31% of the stock is currently owned by institutional investors and hedge funds.
Shares of Intuitive Surgical stock opened at $548.93 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $359.75 and a 12 month high of $581.12. The firm has a market cap of $60.63 billion, a P/E ratio of 76.35, a P/E/G ratio of 3.84 and a beta of 1.03.
In related news, Director Lonnie M. Smith sold 225 shares of Intuitive Surgical stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $540.04, for a total transaction of $121,509.00. Following the completion of the sale, the director now directly owns 379,175 shares of the company’s stock, valued at $204,769,667. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Marshall Mohr sold 7,500 shares of Intuitive Surgical stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $525.00, for a total value of $3,937,500.00. Following the sale, the vice president now directly owns 17,321 shares of the company’s stock, valued at $9,093,525. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 44,159 shares of company stock valued at $22,389,099. 2.20% of the stock is owned by insiders.
ISRG has been the subject of several research analyst reports. Piper Jaffray Companies upgraded Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 price objective for the company in a research report on Tuesday, October 9th. Morgan Stanley boosted their target price on Intuitive Surgical from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, October 11th. Wells Fargo & Co boosted their target price on Intuitive Surgical from $575.00 to $635.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 12th. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, November 29th. Finally, UBS Group assumed coverage on Intuitive Surgical in a research report on Tuesday, November 27th. They set a “neutral” rating and a $540.00 target price for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and sixteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $552.41.
TRADEMARK VIOLATION WARNING: “Intuitive Surgical, Inc. (ISRG) Shares Bought by Gagnon Securities LLC” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2018/12/04/intuitive-surgical-inc-isrg-shares-bought-by-gagnon-securities-llc.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Article: How To Calculate Debt-to-Equity Ratio
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.